As of September 2024 Abiomed has a market cap of A$25.76 Billion. This makes Abiomed the world's 1090th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.